Physician profile
Edward Daniel Young
NPI 1306840772
$3,068.64
in general payments reported to CMS, 2019-2025
22 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $111 · 2021: $180 · 2022: $460 · 2023: $400 · 2024: $925 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781 · Travel and Lodging: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,780.53 |
| Travel and Lodging | $384.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,150.01 | 2020-2025 | Real Intelligence, Journey II, Ri Hip Navigation |
| Stryker Corporation | $700.36 | 2019-2025 | Aequalis Ascend Flex, Aequalis Flex Revive, Pangea |
| Zimmer Biomet Holdings, INC. | $336.59 | 2019-2025 | Mymobility Platform, Persona, Gel-One Cross-Linked Hyaluronate |
| Merz North America, INC. | $137.57 | 2023 | Xeomin |
| Depuy Synthes Sales INC. | $114.42 | 2019-2025 | Monovisc, Orthovisc |
| Team 1, LLC | $96.01 | 2019-2025 | |
| Vertex Pharmaceuticals Incorporated | $77.85 | 2025 | |
| Ebi, LLC | $58.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $58.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zimvie INC. | $42.79 | 2023 | |
| Heraeus Medical, LLC. | $41.98 | 2022-2023 | Palacos |
| Bioventus LLC | $38.45 | 2019-2025 | Durolane |
| Access Pro Medical, LLC | $31.84 | 2023 | Matriderm |
| Innovation Technologies INC | $28.49 | 2025 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $27.85 | 2023 | Seglentis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $27.18 | 2024 | Prevena |
| Dynasplint Systems INC. | $26.92 | 2023-2025 | Dynasplint |
| Fidia Pharma USA INC. | $16.30 | 2020 | |
| Biotissue Holdings INC. | $14.80 | 2023 | |
| Djo, LLC | $14.39 | 2019 | |
| Mimedx Group, INC. | $14.33 | 2025 | |
| Orthofix Medical, INC. | $13.57 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.